Global Next-Generation Sequencing Sample Preparation Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Next-Generation Sequencing Sample Preparation Market” is a recent report generated by MarketResearch.biz. The study and analysis were administered using expert opinions and inputs. This has been done through thorough primary and secondary research efforts to determine various aspects of the next-generation sequencing sample preparation market. The market segmentation allows for deeper thought and understanding to strongly assess, analyze, and study. Besides revenues for segments, the global, regional, and country-wise market revenue segmentation has been compiled in a veracious manner for clear understanding and flow. The global next-generation sequencing sample preparation market report has been segmented on the basis of work-flow, application, end-use, and region.
Next-generation sequencing (NGS) is the technology that allows one to establish the sequence of a DNA molecule(s) in a single experiment. Next-generation sequencing enables researchers to perform a wide variety of applications and to study biological systems at a level that was never possible before with its scalability, speed, and ultra-high throughput.
The global next-generation sequencing sample preparation market was valued at US$ XX Billion in 2019, and is projected to register substantially high CAGR over the 10-year forecast period. Systematized pre-sequencing planning such as library preparation and target enrichment is expeted to lead to generation of accurate, high-quality sequencing data.
The availability of standardized sample preparation formalities as a result of on-going advancements in the field of NGS sample preparation is driving significant growth of the global Next-Generation Sequencing Sample Preparation Market. Improvements in sequencing technologies are pushing the boundaries for sample preparation protocols and capacity expansion.
The tracking, organization, and generation of large amounts of sequencing data have become a hindrance to most voluminous laboratories. As such, the advancement of advanced electronic solutions in order to administrate NGS samples has caused a surge in market growth.
Electronic solutions are in the form of software for information management such as whole laboratory information management systems (LIMSs), electronic lab notebooks, automation and spreadsheets. What has given rise to automation in NGS sample preparation is the maturation of automated and integrated informatics and advancements in mechanical protocols. This has had a significant impact on growth of the global market.
In accordance with system requirements, robots can locate reagents and easily operate on a particular sample according to requirements. Another factor that has added to the ease of locating samples during each step of the sequencing process is the addition of lasers and cameras.
The enhancement of the rapidity of superior library preparation is another area of focus that many companies are targeting. Various major players are also focused on augmentation of effective protocols for sample preparation to ensure success of the sequencing process, regardless of input. The combination of automated and manual protocols for lab preparation is what has made this possible. In 2018, semi-automated labs possessed largest revenue share of the market and are slated to continue their dominance in the foreseeable future.
Innovation in the automation of complex library preparation protocols has paved the way for comparatively less hands-on time and will allow for lab professionals to be much more productive with respect to their individual headcounts. That being said, for laborotories that cannot afford to acquire a robot, advancements must be made to increase the adoption of automated protocols.
With regards to application, the oncology segment in 2018, has accounted for a major portion of the global next-generation sequencing sample preparation market.
As for end-user insights, the clinical research faction segment revenue is expected to expand at highest CAGR over the 10-year forecast period. The propinquity of clinical research by market players such as Thermo Fisher Scientific Corporation, and Illumina, among others, meant for target detection and enrichment is expected to drive revenue growth of the segment.
The largest revenue share in the global next-generation sequencing sample preparation market space has been accredited to North America (NA), and the NA market is projected to maintain dominant position over the foreseeable future. The developments in personalized medicine, companion diagnostics, and next-generation sequencing can be attributed to the slated market’s growth.
Moreover, high investments in R&D, robust presence of major players, and a R&D of technologically advanced products in healthcare sector are factors that are expected to drive the biotech and supplementary markets in the region. The Asia Pacific market is projected to register at a exponentially high CAGR over the 10-year forecast period.
Global Market Segmentation:
Global market segmentation, by Workflow:
- NGS Library Preparation Kits
- Semi-automated Library Preparation
- Automated Library Preparation
- Clonal Amplification
Global market segmentation, by Application:
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
Global market segmentation, by End-Use:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
Global market segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Congenica Ltd.
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- Foundation Medicine Inc.
- Intrexon Bioinformatics Germany GmbH
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!